Corrigendum: Role of NAFLD on the health related QoL response to lifestyle in patients with metabolic syndrome: The PREDIMED plus cohort.
Martínez-Urbistondo D, San-Cristóbal R, Villares P, Martínez-González MÁ, Babio N, Corella D, Del Val JL, Ordovás JM, Alonso-Gómez ÁM, Wärnberg J, Vioque J, Romaguera D, López-Miranda J, Estruch R, Tinahones FJ, Lapetra J, Serra-Majem JL, Bueno-Cavanillas A, Tur JA, Marcos A, Pintó X, Delgado-Rodríguez M, Matía-Martín P, Vidal J, Vázquez C, Ros E, Vela MVB, Palau A, Sorli JV, Masagué M, Abete I, Moreno-Rodríguez A, Candela-García I, Konieczna J, García-Ríos A, Juárez OL, Portolés O, Martín P, Goday A, Zulet MÁ, Vaquero-Luna J, Orea MDCS, Megías I, Baltasar E, Martínez JA, Daimiel L.
Martínez-Urbistondo D, et al. Among authors: vioque j.
Front Endocrinol (Lausanne). 2023 Jan 11;13:1113532. doi: 10.3389/fendo.2022.1113532. eCollection 2022.
Front Endocrinol (Lausanne). 2023.
PMID: 36714565
Free PMC article.